Peptide Purity & COA Verification for Research
COA Verification
HPLC Testing
Last Updated: May 2026
The single most consequential decision a researcher makes when sourcing peptides is not which supplier offers the lowest price — it is which supplier can prove, with verifiable analytical documentation, exactly what is in the vial. Purity and identity are not assumed qualities in the research peptide market; they are measured quantities, and only compounds with documented Certificate of Analysis (COA) data from accredited third-party laboratories should ever be introduced into a controlled research environment. Whether your laboratory programme involves tissue remodelling research with BPC-157 10mg, extracellular matrix studies using TB-500 10mg, or secretagogue research with GHRP-2 10mg, the integrity of your data is directly contingent on the integrity of your starting material. This guide explains exactly what a legitimate COA contains, how HPLC and LC-MS testing work, how to identify fraudulent or inadequate documentation, and the purity thresholds that define research-grade standard.
Key Takeaways
- Research-grade peptides require a minimum HPLC purity of ≥98% — with ≥99% preferred for sensitive assays including receptor binding studies, cell signalling experiments, and gene expression analysis where impurity-driven confounders must be eliminated.
- A legitimate Certificate of Analysis must contain six mandatory data points: compound identity confirmation, purity percentage, test date, batch number, full analytical method description, and the name and verifiable contact details of the issuing third-party laboratory — any COA missing these elements cannot be treated as verification.
- HPLC measures how pure a compound is (percentage of target molecule in the sample); LC-MS confirms what the compound actually is by measuring molecular mass — both tests are required for a compound to be genuinely research-grade verified.
- Fake or inadequate COAs share identifiable characteristics: no batch number, no test date, an unverifiable laboratory name, no HPLC chromatogram, and identical documents reused across multiple products or batches — recognising these patterns is the first line of quality defence.
- Independent verification through accredited laboratories such as Eurofins Scientific (ISO 17025-accredited) costs approximately £100–300 per compound and provides the highest level of assurance for research programmes where compound identity and purity are critical variables.
HPLC-Verified Research Peptides — Batch-Specific COA Included
Every compound in the Pure Grade Labs catalogue ships with batch-specific HPLC purity data from an accredited third-party laboratory. Verification is not a feature — it is the standard.
What Is a Certificate of Analysis (COA)?
A Certificate of Analysis is the primary quality assurance document in research chemical supply. It is an analytical record produced by a laboratory that tested the compound, confirming what was analysed, which methods were used, and what the results showed. In the context of peptide research, a COA serves as the bridge between the manufacturer’s production process and the researcher’s confidence that the compound being introduced into an experiment is what it claims to be, at the purity level stated.
The COA functions as a chain of custody document. From the synthesis facility, through QC testing, to the researcher’s bench — every step should be traceable to a specific batch, a specific analytical run, and a specific result. This traceability is what separates a genuine COA from a generic template: a real document references the exact batch tested, not a historical or hypothetical result repurposed across multiple products.
For a COA to function as a verification document rather than a marketing artefact, it must be issued by a laboratory that is independent of the supplier, accredited to an internationally recognised standard such as ISO/IEC 17025, and verifiable by the researcher through independent means. An in-house COA produced by the manufacturer carries no independent verification value — it represents the manufacturer’s own assessment of their own product, which is precisely the conflict of interest that third-party testing exists to eliminate.
HPLC vs LC-MS: What These Tests Actually Measure
The two analytical techniques appearing on the majority of peptide COAs are High-Performance Liquid Chromatography (HPLC) and Liquid Chromatography–Mass Spectrometry (LC-MS). These methods answer different questions about a compound’s quality, and understanding what each test reveals — and what it cannot detect — is essential for evaluating whether a COA provides adequate quality assurance.
HPLC: Measuring Purity by Peak Area
HPLC works by dissolving the compound in a mobile phase and passing it through a stationary phase column under high pressure. Different molecular species travel through the column at different rates depending on their polarity and affinity for the stationary phase, producing a chromatographic separation. The detector — typically a UV absorbance detector set at a wavelength where the target peptide absorbs strongly, commonly 214 nm for peptide bond detection — records the absorbance signal over time, generating a chromatogram: a graph of signal intensity against retention time.
Each distinct molecular species in the sample produces a separate peak. Purity is calculated as the percentage of the total peak area attributable to the target compound’s peak. A result of 99.1% purity means 99.1% of the UV-detectable material in the sample corresponds to the target peptide’s retention time. The remaining 0.9% comprises other peaks — potentially truncated synthesis fragments, degradation products, or residual synthesis impurities.
HPLC’s limitation is that it measures purity by peak area, not identity. A sample could theoretically read 99% HPLC purity and contain the wrong peptide entirely — if the wrong compound happens to elute at the same retention time as the target, HPLC would not detect the substitution. This is why HPLC purity alone, while necessary, is insufficient for complete identity verification.
LC-MS: Confirming Molecular Identity
LC-MS adds a mass spectrometer to the chromatographic separation. As compounds elute from the column, they are ionised and passed into the mass spectrometer, which measures their mass-to-charge ratio (m/z) with high precision. This generates a molecular weight fingerprint for each compound in the sample — a measurement that is essentially unique for each distinct molecular structure.
For a peptide, the expected molecular mass is calculated from its amino acid sequence and can be predicted with high precision. LC-MS confirms that the compound in the sample has the molecular mass consistent with the claimed sequence — providing identity confirmation that HPLC alone cannot offer. A compound returning both the correct HPLC retention time and the correct LC-MS molecular mass is, within analytical confidence limits, confirmed to be what it claims to be.
In practical terms: HPLC tells you how pure the sample is; LC-MS tells you what it actually is. Responsible suppliers provide both datasets on their COAs. If only HPLC data is available, the purity figure can be accepted provisionally, but identity remains unconfirmed. If no mass spectrometry data is provided, independent verification becomes especially important before use in any research context where compound identity is material to the experiment.
Which Method Is Better for What?
HPLC is the standard purity test and is sufficient for routine quality control in many research contexts. LC-MS is preferred when: (1) compound identity must be unambiguously confirmed before use in critical experiments; (2) the research involves complex peptides where sequence variants could produce different biological activity; (3) the supplier is new and their quality standards have not been established; or (4) the compound is expensive or rare and substitution risk justifies the additional analytical cost. For serious research programmes, both methods together represent the minimum acceptable analytical standard.
The 6 Elements Every Legitimate COA Must Include
A complete Certificate of Analysis for a research-grade peptide must contain the following six data points without exception. Any document missing one or more of these elements cannot be considered a valid verification record.
- Compound Identity Confirmation — The full compound name, amino acid sequence (for peptides), and CAS number, confirmed by LC-MS molecular mass match. This establishes that the compound is what it claims to be at a molecular level, not just by label.
- Purity Percentage — The HPLC result expressed as the percentage of the sample that is the target compound, calculated from peak area integration. The figure should appear alongside the analytical method and detection parameters (wavelength, column specification). Research-grade minimum: ≥98%.
- Test Date — The date on which the analytical run was performed. Undated COAs cannot be assessed for relevance — analytical data from a batch tested two years ago does not speak to the current batch’s purity, particularly for compounds with known degradation profiles. For research-critical procurement, a COA older than 12–18 months without a retest date is a concern.
- Batch Number — A unique alphanumeric identifier that links the COA to the specific production batch analysed. This batch number should match the batch number on the vial label. If it does not, the COA does not apply to the product received, regardless of what the purity figure says.
- Analytical Method — The full specification of the testing methodology: the instrument type (e.g., reverse-phase HPLC, triple-quadrupole LC-MS), column specification (stationary phase, column dimensions), mobile phase composition, flow rate, detection wavelength or mass spectrometry parameters, and any relevant sample preparation steps. This detail allows the analysis to be independently reproduced and its validity assessed.
- Laboratory Name and Verifiable Contact Details — The name of the third-party laboratory that conducted the analysis, with a verifiable physical address, website, and accreditation number. The laboratory should be independently findable through a search unconnected to the supplier. An ISO/IEC 17025 accreditation number from a national accreditation body (UKAS in the UK, DAkkS in Germany, A2LA in the USA) provides the strongest confirmation of laboratory competence.
In addition to these six mandatory elements, a high-quality COA will also include the raw HPLC chromatogram (the graphical peak data, not just the calculated purity figure), residual solvent testing results, and water content analysis. These additional data points go beyond the minimum and are the mark of a supplier operating to pharmaceutical-adjacent standards.
How to Spot a Fake or Generic COA
The research peptide market contains a segment of suppliers who circulate COA documents that have no analytical validity — either fabricated, repurposed from a different batch or compound, or generated as a template without any laboratory analysis behind them. Experienced researchers can identify these documents from a structured review of the key fields, without any specialist analytical knowledge required.
Document-Level Red Flags
- No batch number present. This is the single most reliable indicator of a template document. A batch number is generated during the production process — without it, there is no link between the document and any specific production run. A COA without a batch number is a generic document, not an analytical certificate.
- No test date, or a suspiciously round date. Analytical runs produce results on specific days. A COA listing a vague month-and-year or a suspiciously symbolic date (January 1st, dates that coincide with business milestones) should be scrutinised — genuine analytical reports are dated to the specific day the run was performed.
- Purity figure without a supporting chromatogram. HPLC purity is derived from chromatogram peak integration. A COA showing a purity percentage but no chromatogram graphic cannot be cross-checked. Any supplier providing purity data without the underlying chromatogram data is providing an assertion, not a verification.
- Unverifiable laboratory name. Search the laboratory name independently — not via a link provided by the supplier. If the laboratory cannot be found independently, holds no verifiable accreditation, and has no physical address, the document’s authenticity is in serious doubt.
- Identical COA across multiple products. A legitimate supplier maintains separate batch-specific COAs for each product and each production run. If the same document (same date, same batch number, same result) appears across multiple different compounds in a catalogue, it is a template, not a genuine batch certificate.
- Purity percentages that are implausibly round. Genuine HPLC results return values to one or two decimal places: 98.7%, 99.1%, 98.4%. A COA showing exactly 99% or exactly 98% as a round integer — particularly across multiple products — is inconsistent with real analytical output.
Supplier Behaviour Red Flags
- COA only available on request after purchase. Legitimate suppliers make COA data accessible before purchase — at the product page level or via a batch verification lookup tool. A supplier who requires payment before providing analytical data is limiting your ability to make an informed procurement decision.
- Inability to provide the raw HPLC chromatogram file. The chromatogram is the core analytical output of an HPLC run — it is the graph, not just the calculated number. If a supplier cannot provide the chromatogram on request, they either do not possess it (meaning the analysis was not performed) or are unwilling to share it (which raises the question of what the peak profile reveals).
- Reluctance to disclose the testing laboratory. If a supplier will not name the laboratory or claims the laboratory is confidential, independent verification of the COA is impossible by design.
Purity Thresholds: What “Research Grade” Actually Means
The term “research grade” carries a specific purity expectation in analytical chemistry — it is not a general marketing claim that suppliers can apply arbitrarily. In the peptide supply context, research grade is defined by a minimum HPLC purity of ≥98%, with identity confirmed by LC-MS. This threshold exists for a reason rooted in research validity, not regulatory preference.
Why ≥98% Is the Minimum, Not the Target
At 98% purity, 2% of the sample is comprised of material that is not the target compound. In most basic in vitro research contexts — cell viability assays, simple receptor binding studies, preliminary screening experiments — this impurity load is below the threshold that would produce measurable confounders. This is the minimum acceptable threshold for entry into research-grade status.
At 95% purity — a threshold sometimes marketed as “pharmaceutical grade” by lower-quality suppliers — the impurity load rises to 5%. In a cell signalling study where nanomolar concentrations of compound are applied to a cell culture, a 5% impurity fraction containing truncated peptide sequences with partial receptor affinity can produce signal that is indistinguishable from the target compound’s effect. The research reads as internally consistent but is contaminated at the starting material level.
At 90% purity — common in low-cost grey-market supply — the contamination load is significant enough to affect cell viability assays, alter dose-response curves, and produce cytotoxic effects in cell lines attributable to synthesis by-products (residual TFA salt, for instance) rather than the peptide under study. Research conducted with 90% purity material is, in most serious research contexts, not publishable.
≥99% for Sensitive Assays
For receptor binding studies (where non-target peptide fragments may occupy binding sites), gene expression analysis (where impurities may activate stress response pathways), and any research designed to produce publishable data, ≥99% HPLC purity reduces the impurity load to a level where confounders from synthesis by-products can be discounted with confidence. This is the standard Pure Grade Labs targets for its highest-sensitivity compounds, and the standard used by research groups whose data is intended for peer review.
Independent Verification: When to Pay for Eurofins or Similar
Independent third-party verification — submitting a received compound sample to an accredited analytical laboratory for testing, independent of both the supplier and their stated COA — represents the highest level of quality assurance available to researchers. It eliminates any possibility of COA misrepresentation and provides data that is entirely under the researcher’s control, not the supplier’s.
Eurofins Scientific operates ISO 17025-accredited analytical chemistry services across Europe, including a UK-based pharmaceutical testing division. For a standard peptide HPLC purity analysis with LC-MS identity confirmation, the typical cost is in the range of £100–300 per compound, depending on the scope of testing requested and whether additional panels (residual solvents, water content, endotoxin testing) are included.
Independent verification is warranted when:
- The research programme is designed to produce peer-reviewed data where compound quality will be scrutinised at the publication stage
- A new supplier is being evaluated for the first time, and their quality claims have not been independently validated
- The compound in question is expensive, rare, or critical to the research timeline — and the cost of discovering a purity problem mid-experiment would far exceed the verification cost
- The received compound shows anomalous behaviour in preliminary testing — unexpected solubility, colour, or potency — that is inconsistent with prior experience with the same compound
- The supplier’s COA is missing one or more of the six mandatory data points described above, but the compound is needed immediately
For routine procurement from established suppliers with a track record of providing batch-specific COAs from accredited laboratories, independent verification of every batch is not necessary — the supplier’s COA documentation serves its purpose. The decision to independently test should be risk-weighted: higher-stakes research contexts warrant more rigorous verification; routine screening experiments may not.
When submitting a compound for independent testing, provide a clear chain of custody: record the batch number, supplier, receipt date, and storage conditions from receipt to submission. This documentation becomes part of the research record and, if results deviate from the supplier’s COA, provides the basis for a formal quality dispute.
Pure Grade Labs COA Standards
Pure Grade Labs was established on the principle that the research community deserves documentation transparency that matches the rigour of the research itself. Every compound in our catalogue — from BPC-157 10mg through to GHRP-2 10mg — is supplied with a batch-specific COA linked directly to the vial received, not a generic document.
Our supplier qualification process requires that all manufacturers provide HPLC and LC-MS analytical data from accredited third-party laboratories for every production batch. We do not accept in-house testing from the manufacturer as a substitute for independent verification. At the UK side, we are building out independent Eurofins testing protocols for our highest-volume compounds — cross-checking manufacturer batch data against independently conducted analysis at our own cost, before product reaches a researcher’s hands.
Every Pure Grade Labs vial label carries a QR code that links directly to the batch-specific COA for the compound in that vial. This is not a marketing feature — it is the minimum documentation standard that serious researchers should expect. The QR code links to an online lookup page where the batch number, HPLC purity result, test date, and laboratory details can be reviewed before the compound is introduced into any experimental context.
Our TB-500 10mg and BPC-157 batches are targeted for independent Eurofins verification as our first independent testing tranche. Where independent testing confirms the manufacturer’s COA data, that result is published alongside the original. Where it reveals discrepancy, we do not release the affected batch. This is what research-grade supply standard actually requires — not a purity claim on a product page, but a documented, verifiable, batch-specific trail from synthesis to shelf.
For reconstitution of lyophilised compounds in laboratory settings, Bacteriostatic Water 10ml is available as a laboratory-grade vehicle — sterile water with 0.9% benzyl alcohol providing bacteriostatic protection for multi-use vials and extending the usable life of reconstituted solutions to 28 days at 4°C.
COA Field Verification Checklist
| COA Field | What to Look For | Red Flag |
|---|---|---|
| Compound Identity | Full name, amino acid sequence, and CAS number confirmed by LC-MS molecular mass match | No CAS number listed; no LC-MS confirmation; identity stated by label only |
| Purity Percentage | HPLC result to 1–2 decimal places (e.g., 98.7%). Research-grade: ≥98% | Round integer (exactly 99% or 98%); no decimal precision; result without supporting chromatogram |
| Test Date | Specific day/month/year matching the batch production timeline. Recent or within 18 months | No date; vague “Year 2024” date; suspiciously round date; date older than 18–24 months |
| Batch Number | Unique alphanumeric code matching the batch number on the vial label received | No batch number; generic “Lot 001” across multiple products; mismatch with vial label |
| Analytical Method | HPLC column spec, mobile phase, detection wavelength (e.g., 214 nm); or MS parameters for LC-MS | Method described only as “HPLC” with no further detail; no instrument or protocol specification |
| Laboratory Name & Contact | Independently verifiable lab name, address, website, and accreditation number (ISO 17025 preferred) | Unverifiable lab name; no contact details; lab only findable through supplier’s own links |
| HPLC Chromatogram | Raw graphical chromatogram output showing separation peaks, retention times, and area integration | Purity number provided but no chromatogram included; supplier unable to provide chromatogram on request |
| Lab Accreditation | ISO/IEC 17025 or equivalent from UKAS (UK), DAkkS (Germany), or A2LA (USA) | No accreditation number; accreditation claimed but not verifiable; self-certified quality system only |
Verification You Can Actually Check
Every Pure Grade Labs batch ships with a QR code linked to its specific COA — HPLC purity, test date, batch number, and lab details. No generic templates. No unverifiable claims.
Case Study: The Generic COA Problem
A UK-based independent research group sourcing peptides for a tissue remodelling study received a COA from a grey-market supplier alongside their first order. The document looked professional — company letterhead, a purity figure of 99% (a suspiciously round number), a laboratory name, and a result date. On closer examination: no batch number appeared anywhere on the document; the laboratory listed could not be found via any search engine independently of the supplier’s own links; and the same document, with only the compound name changed, appeared for three different products in the supplier’s catalogue — same date, same round purity figure, same lab name.
The group submitted the received compound to Eurofins for independent HPLC analysis. The result came back at 91.3% purity, with two unidentified impurity peaks accounting for approximately 5.8% and 2.9% of the peak area respectively. Four weeks of preliminary in vitro data was discarded. The group subsequently sourced from a supplier providing batch-specific COAs with Eurofins letterhead, verifiable accreditation numbers, and chromatogram data — and the received compound returned 98.9% HPLC purity on independent retest. The research programme resumed with confidence in the starting material.
The signals were visible before the order was placed: the round purity figure, the absence of a batch number, and the identical COA format across multiple products. In retrospect, each of these should have been a decisive reason to source elsewhere.
Frequently Asked Questions
What is the minimum acceptable purity for research-grade peptides?
The research-grade minimum is ≥98% HPLC purity — the threshold at which the impurity load (the non-target fraction) is below the level at which it reliably confounds most in vitro research applications. For sensitive assays including receptor binding studies, gene expression analysis, and cell signalling experiments, the preferred standard is ≥99%. Compounds below 98% HPLC purity — regardless of what label they carry — should not be used in research contexts where compound quality is material to result validity.
What is the difference between HPLC and LC-MS testing?
HPLC (High-Performance Liquid Chromatography) measures compound purity by separating molecular species and calculating the percentage of the sample attributable to the target compound’s peak area. It tells you how pure the sample is, but not definitively what it is. LC-MS (Liquid Chromatography–Mass Spectrometry) adds mass spectrometry to the separation step, providing molecular mass data that confirms the compound’s identity at a molecular level. HPLC purity and LC-MS identity confirmation together constitute the minimum analytical standard for research-grade peptides — HPLC alone is insufficient for identity verification, and LC-MS without purity data does not tell the researcher what proportion of the sample is the target compound.
How do I know if a COA is batch-specific?
A batch-specific COA carries a unique alphanumeric batch number that matches the batch number printed on the vial label you received. This number is generated during the production process and links the analytical certificate to the specific synthesis batch tested. If the COA has no batch number, the document is generic — it does not apply to any specific batch, and may represent historical testing data, testing of a different supplier’s stock, or no testing at all. Cross-referencing the COA batch number against your vial label is the first and most important verification step for any received compound.
Can I request independent verification of a supplier’s COA?
Yes — and in high-stakes research contexts, this is recommended. Researchers can submit a sample of the received compound to an accredited analytical laboratory (such as Eurofins Scientific, which operates ISO 17025-accredited pharmaceutical testing services in the UK) for independent HPLC and LC-MS analysis. The typical cost is £100–300 per compound depending on the analytical panel requested. If independent results differ materially from the supplier’s stated COA, this constitutes a formal quality dispute and provides documented grounds for a refund or replacement claim. Responsible suppliers will not resist customers independently verifying their products.
What makes a COA fraudulent or low-quality?
The clearest indicators of a fraudulent or inadequate COA are: absence of a batch number; no test date; a laboratory name that cannot be verified independently; the same COA document reused across multiple products or batches; suspiciously round purity figures (exactly 99% or 98% as integers); and the absence of any supporting chromatogram data. Low-quality COAs typically result from suppliers who either do not conduct analytical testing at all and fabricate the documentation, or who use a single historical test result as a template applied to all subsequent batches without retesting. Either practice produces a document that looks superficially like a COA but carries no actual verification value.
Does Pure Grade Labs provide batch-specific COAs?
Yes. Every Pure Grade Labs compound ships with a batch-specific COA referenced to the exact batch in the vial. The batch number on the vial label matches the batch number on the COA document. A QR code on the vial label links directly to the batch COA hosted online, allowing researchers to verify purity data, test date, and laboratory details before introducing the compound into any experiment. For our highest-volume compounds, we are additionally conducting independent Eurofins verification — cross-checking manufacturer batch data with independently conducted testing at our own cost. Where independent results confirm the manufacturer’s COA, both results are published. Where they do not, the batch is not released.
Research With Compounds You Can Actually Verify
Pure Grade Labs: batch-specific COA, QR-linked verification, HPLC-confirmed purity, and Eurofins independent testing for top sellers. The documentation standard your research deserves.
Summary
Peptide purity and COA verification are not administrative formalities — they are the analytical foundation on which research validity rests. A compound without a batch-specific, third-party verified COA is, from an analytical standpoint, an unknown quantity. Its purity could be anywhere on the spectrum; its identity is unconfirmed; and any data generated from it cannot be attributed with confidence to the compound under study.
The minimum research-grade standard — ≥98% HPLC purity with LC-MS identity confirmation, batch-specific COA from an ISO 17025-accredited laboratory — is the floor, not the ceiling. Researchers who apply this standard consistently to their supplier evaluation process protect not just individual experiments, but the integrity of their entire research programme.
The six mandatory COA fields — compound identity, purity percentage, test date, batch number, analytical method, and laboratory contact — provide a rapid verification framework that any researcher can apply in minutes before procurement. The red flags — no batch number, round purity figures, unverifiable laboratory names, identical documents across multiple products — are equally identifiable without specialist knowledge.
Where the stakes are highest — publishable data, expensive research timelines, rare compound procurement — independent verification through Eurofins or equivalent at £100–300 per compound is the rational choice. The cost of discovering a purity problem six weeks into an experiment, as the case study above illustrates, is an order of magnitude greater. For BPC-157, TB-500, GHRP-2, and all other compounds sourced for serious research — the verification infrastructure around the compound matters as much as the compound itself.
References
- International Organization for Standardization. ISO/IEC 17025:2017 — General requirements for the competence of testing and calibration laboratories. ISO, Geneva. Available at: iso.org
- European Medicines Agency. ICH Q2(R1) — Validation of Analytical Procedures: Text and Methodology. EMA, Amsterdam, 2005. Available at: ema.europa.eu
- European Medicines Agency. ICH Q6A — Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances. EMA, 1999.
- Eurofins Scientific. Pharmaceutical Testing Services — Peptide and Oligonucleotide Analysis. Available at: eurofins.com/pharmaceutical-services
- UKAS (UK Accreditation Service). ISO/IEC 17025 accreditation for testing and calibration laboratories. Available at: ukas.com
- Snyder LR, Kirkland JJ, Dolan JW. Introduction to Modern Liquid Chromatography, 3rd ed. Wiley-Interscience, 2010. ISBN: 978-0-470-16754-0
- Gross J. Mass Spectrometry: A Textbook, 3rd ed. Springer, 2017. doi:10.1007/978-3-319-54398-7
- MHRA. Guidance on the regulatory framework for medicines in the UK. Medicines and Healthcare products Regulatory Agency. Available at: gov.uk/mhra
- UK Statutory Instrument 2012 No. 1916 — The Human Medicines Regulations 2012. Available at: legislation.gov.uk
- Sikiric P, et al. (2018). Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract. Current Pharmaceutical Design, 24(18), 1938–1956. PMID: 29879893